| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From Roche Molecular Systems, Inc., Pleasanton, California
We developed a homogeneous format reverse transcription-polymerase chain reaction assay for quantitating hepatitis C virus (HCV) RNA based on the TaqMan principle, in which signal is generated by cleaving a target-specific probe during amplification. The test uses two probes, one specific for HCV and one specific for an internal control, containing fluorophores with different emission spectra. Titers are calculated in international units (IU)/ml by comparing the HCV signal generated by test samples to that generated by a set of external standards. Endpoint titration experiments demonstrated that samples containing 28 IU/ml give positive results 95% of the time. Based on these data, the limit of detection was set conservatively at 40 IU/ml. All HCV genotypes were amplified with equal efficiency and accurately quantitated: when equal quantities of RNA were tested, each genotype produced virtually identical fluorescent signals. The test exhibited a linear range extending from 64 to 4,180,000 IU/ml and excellent reproducibility, with coefficients of variation ranging from 21.6 to 30.4%, which implies that titers that differ by a factor of twofold (0.3 log10) are statistically significant (P = 0.005). The test did not react with other organisms likely to co-infect patients with hepatitis C and exhibited a specificity of 99% when evaluated on a set of samples from HCV seronegative blood donors. In interferon-treated patients, the patterns of viral load changes revealed by the TaqMan HCV quantitative test distinguished responders from nonresponders and responder-relapsers. These data indicate that the TaqMan quantitative HCV test provides an attractive alternative for measuring HCV viral load and should prove useful for prognosis and for monitoring the efficacy of antiviral treatments.
This article has been cited by other articles:
 |
|
 |
|
  P. Huang, D. A. Goff, Q. Huang, A. Martinez, X. Xu, S. Crowder, S. D. Issakani, E. Anderson, N. Sheng, P. Achacoso, et al. Discovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus Replication Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1419 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Sabato, M. L. Shiffman, M. R. Langley, D. S. Wilkinson, and A. Ferreira-Gonzalez Comparison of Performance Characteristics of Three Real-Time Reverse Transcription-PCR Test Systems for Detection and Quantification of Hepatitis C Virus J. Clin. Microbiol., August 1, 2007; 45(8): 2529 - 2536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Laurent, K. Le Roux, P. Grivard, G. Bertil, F. Naze, M. Picard, F. Staikowsky, G. Barau, I. Schuffenecker, and A. Michault Development of a Sensitive Real-Time Reverse Transcriptase PCR Assay with an Internal Control to Detect and Quantify Chikungunya Virus Clin. Chem., August 1, 2007; 53(8): 1408 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bartolome, J. M. Lopez-Alcorocho, I. Castillo, E. Rodriguez-Inigo, J. A. Quiroga, R. Palacios, and V. Carreno Ultracentrifugation of Serum Samples Allows Detection of Hepatitis C Virus RNA in Patients with Occult Hepatitis C J. Virol., July 15, 2007; 81(14): 7710 - 7715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Espy, J. R. Uhl, L. M. Sloan, S. P. Buckwalter, M. F. Jones, E. A. Vetter, J. D. C. Yao, N. L. Wengenack, J. E. Rosenblatt, F. R. Cockerill III, et al. Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing Clin. Microbiol. Rev., January 1, 2006; 19(1): 165 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Germer, W. S. Harmsen, J. N. Mandrekar, P. S. Mitchell, and J. D. C. Yao Evaluation of the COBAS TaqMan HCV Test with Automated Sample Processing Using the MagNA Pure LC Instrument J. Clin. Microbiol., January 1, 2005; 43(1): 293 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cook, K.-W. Ng, A. Bagabag, L. Corey, and K. R. Jerome Use of the MagNA Pure LC Automated Nucleic Acid Extraction System followed by Real-Time Reverse Transcription-PCR for Ultrasensitive Quantitation of Hepatitis C Virus RNA J. Clin. Microbiol., September 1, 2004; 42(9): 4130 - 4136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Barbeau, J. Goforth, A. M. Caliendo, and F. S. Nolte Performance Characteristics of a Quantitative TaqMan Hepatitis C Virus RNA Analyte-Specific Reagent J. Clin. Microbiol., August 1, 2004; 42(8): 3739 - 3746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Germer, M. M. Lins, M. E. Jensen, W. S. Harmsen, D. M. Ilstrup, P. S. Mitchell, F. R. Cockerill III, and R. Patel Evaluation of the MagNA Pure LC Instrument for Extraction of Hepatitis C Virus RNA for the COBAS AMPLICOR Hepatitis C Virus Test, Version 2.0 J. Clin. Microbiol., August 1, 2003; 41(8): 3503 - 3508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Brinig, P. W. Lepp, C. C. Ouverney, G. C. Armitage, and D. A. Relman Prevalence of Bacteria of Division TM7 in Human Subgingival Plaque and Their Association with Disease Appl. Envir. Microbiol., March 1, 2003; 69(3): 1687 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ovstebo, K. B. F. Haug, K. Lande, and P. Kierulf PCR-based Calibration Curves for Studies of Quantitative Gene Expression in Human Monocytes: Development and Evaluation Clin. Chem., March 1, 2003; 49(3): 425 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Mackay, K. E. Arden, and A. Nitsche Real-time PCR in virology Nucleic Acids Res., March 15, 2002; 30(6): 1292 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Verstrepen, S. Kuhn, M. M. Kockx, M. E. Van De Vyvere, and A. H. Mertens Rapid Detection of Enterovirus RNA in Cerebrospinal Fluid Specimens with a Novel Single-Tube Real-Time Reverse Transcription-PCR Assay J. Clin. Microbiol., November 1, 2001; 39(11): 4093 - 4096. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
